약물유해반응 이후 처방의 변경 유형과 치료 결과: Lamotrigine 관련 사례 분석
Changes in prescribing patterns and resultant disease control after lamotrigine-related adverse drug reactions: A descriptive analysis
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: This study aimed to describe the desperate situation where the clinician should make decisions to further manage patients having experienced adverse drug reaction (ADR) to lamotrigine that is indicated to not easily controlled neuropsychiatric diseases. Methods: A descriptive analysis was done by thoroughly reviewing medical records of patients who were reported to have ADR to lamotrigine in a regional drug-safety center between 2010 and 2018. Results: Eighty-four cases of lamotrigine-related ADRs occurred in 80 patients. Skin lesions were most commonly observed in 70 cases (83.3%) and 14 cases (16.7%) had severe ADRs. Sixty-three subjects (78.8%) discontinued lamotrigine, while 17 (21.3%) continued it. At the time of discontinuation, 30.0% were prescribed aromatic antiepileptic drugs. Among 4 subjects who were eventually prescribed lamotrigine again after a period of discontinuation, 3 (75.0%) experienced its recurrence. Among patients who had taken alternative medications, the incidence of ADRs was higher in those being prescribed aromatic antiepileptic drugs than in the others being prescribed other than aromatic antiepileptic drugs (P=0.013). Regarding the control of underlying diseases, as many as 65 (86.7%) and 68 (90.7%) failed to reach maintaining the resolved state from 6 months and 12 months after the substitution, respectively. Conclusion: Patients can be easily trapped between the recurrence of ADRs and the treatment failure to a certain drug like lamotrigine, in which we can hardly find a reasonable alternative to manage them.
Abstract
Purpose: This study aimed to describe the desperate situation where the clinician should make decisions to further manage patients having experienced adverse drug reaction (ADR) to lamotrigine that is indicated to not easily controlled neuropsychiatric diseases. Methods: A descriptive analysis was done by thoroughly reviewing medical records of patients who were reported to have ADR to lamotrigine in a regional drug-safety center between 2010 and 2018. Results: Eighty-four cases of lamotrigine-related ADRs occurred in 80 patients. Skin lesions were most commonly observed in 70 cases (83.3%) and 14 cases (16.7%) had severe ADRs. Sixty-three subjects (78.8%) discontinued lamotrigine, while 17 (21.3%) continued it. At the time of discontinuation, 30.0% were prescribed aromatic antiepileptic drugs. Among 4 subjects who were eventually prescribed lamotrigine again after a period of discontinuation, 3 (75.0%) experienced its recurrence. Among patients who had taken alternative medications, the incidence of ADRs was higher in those being prescribed aromatic antiepileptic drugs than in the others being prescribed other than aromatic antiepileptic drugs (P=0.013). Regarding the control of underlying diseases, as many as 65 (86.7%) and 68 (90.7%) failed to reach maintaining the resolved state from 6 months and 12 months after the substitution, respectively. Conclusion: Patients can be easily trapped between the recurrence of ADRs and the treatment failure to a certain drug like lamotrigine, in which we can hardly find a reasonable alternative to manage them.
참고문헌 (19)
- Edwards IR, "Adverse drug reactions : definitions, diagnosis, and management", Lancet, 356, pp.1255~1259 (2000)
- Broyles AD, "Practical guidance for the evaluation and management of drug hypersensitivity : specific drugs", J Allergy Clin Immunol Pract, 8(9S), pp.S16~S116 (2020)
- Mirakian R, "BSACI guidelines for the management of drug allergy", Clin Exp Allergy, 39, pp.43~61 (2009)
- Korean Epilepsy Society, "Clinical guideline for antiepileptic drug treatment in patient with epilepsy" (2015), Korean Epilepsy Society
- Yang W, "Prediction of the recurrence risk in patients with epilepsy after the withdrawal of antiepileptic drugs", Epilepsy Behav, 110, pp.107156~ (2020)
- Gonzalez-Viana E, "Epilepsies in children, young people, and adults : summary of updated NICE guidance", BMJ, 378, pp.o1446~ (2022)
- Hashimoto Y, "Lamotrigine in the maintenance treatment of bipolar disorder", Cochrane Database Syst Rev, 9, pp.Cd013575~ (2021)
- Sun J, "Stevens-Johnson Syndrome and toxic epidermal necrolysis : a multi-aspect comparative 7-year study from the People's Republic of China", Drug Des Devel Ther, 8, pp.2539~2547 (2014)
- Kuyucu S, "Hypersensitivity reactions to antiepileptic drugs in children : epidemiologic, pathogenetic, clinical, and diagnostic aspects", J Allergy Clin Immunol Pract, 6, pp.1879~1891 (2018)
- Mani R, "Rashes and other hypersensitivity reactions associated with antiepileptic drugs : a review of current literature", Seizure, 71, pp.270~278 (2019)
- Tantikul C, "The utility of the World Health Organization-The Uppsala Monitoring Centre(WHO-UMC)system for the assessment of adverse drug reactions in hospitalized children", Asian Pac J Allergy Immunol, 26, pp.77~82 (2008)
- Hartwig SC, "Preventability and severity assessment in reporting adverse drug reactions", Am J Hosp Pharm, 49, pp.2229~2232 (1992)
- Scheffer IE, "ILAE classification of the epilepsies : position paper of the ILAE Commission for Classification and Terminology", Epilepsia, 58, pp.512~521 (2017)
- Andreasen NC, "Remission in schizophrenia : proposed criteria and rationale for consensus", Am J Psychiatry, 162, pp.441~449 (2005)
- 윤보현, "한국형 양극성 장애 약물치료 알고리듬 2014: 총론", 대한정신약물학회지, 25(2), pp.43~56 (2014), 대한정신약물학회
- Andreasen NC, "Remission in schizophrenia : proposed criteria and rationale for consensus", Am J Psychiatry, 162, pp.441~449 (2005)
- Terao T, "Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder : post-marketing surveillance study report", Neuropsychiatr Dis Treat, 13, pp.1441~1448 (2017)
- Wang XQ, "Lamotrigine-induced severe cutaneous adverse reaction : update data from 1999-2014", J Clin Neurosci, 22, pp.1005~1011 (2015)
- Wang XQ, "Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population", Seizure, 19, pp.562~566 (2010)